| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |